Sign in

NCT04735640Completed

Effectiveness of a Nurse-led Personalized Telephone Intervention on Lifestyle Changes in Diabetes Prevention.

Effects of a 9-months Nurse-led Telephone Personalized Lifestyle Intervention Versus Automated SMSs on Nutritional and Physical Activity Advice on Glucose Profile in Patients With Prediabetes

Source: ClinicalTrials.gov · Last updated 8 Jul 2024

Brief summary (registry, in English)

A randomized, 9-months, parallel-group study comparing the effectiveness of a nurse-led telephone personalized lifestyle intervention versus automated SMSs on nutritional and physical activity advice in the reduction of fasting blood glucose and/or HbA1c in a population with prediabetes.

Status (registry)
Completed
Study type
Interventional
Enrollment
206 (actual)
First submitted
29 Jan 2021
Start date
13 Apr 2021
Primary completion date
27 Sept 2023
Lead sponsor
University of the Balearic Islands
NCT number
NCT04735640

What you commit to

  • Study type: Interventional
  • Participants enrolled: 206
  • From 13 Apr 2021 to the primary completion date, 27 Sept 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Major surgery or hospital stay during the previous 3 months
  • Concomitant active participation in another clinical trial

Other illness

  • Documented history of T2DM or use of oral antidiabetic medication
  • Terminal illness
  • Institutionalization, dementia or cognitive impairment
  • Presence of any medical or psychological condition that may limit the ability of the patient to participate in the study

Lab values

  • Documented history of hematologic disease which may interfere with the HbA1c measurement

Other

  • Pregnancy

Who the study is looking for

  • Fasting plasma glucose between 100 and 125 mg/dL OR HbA1c between 5.7 and 6.4%
  • BMI ≥ 27 and \< 40 kg/m2
  • Written informed consent

Age in the registry: 20 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of the Balearic Islands
Coordinator of this site? Confirm its status
Palma de MallorcaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.